Altered fracture callus formation in chondromodulin (cas 136362-10-2)-I deficient mice
-
Add time:09/05/2019 Source:sciencedirect.com
Chondromodulin-I (Chm-I) is a glycoprotein that stimulates the growth of chondrocytes and inhibits angiogenesis in vitro. Mice lacking the Chm1 gene show abnormal bone metabolism and pathological angiogenesis in cardiac valves in the mature stage although they develop normally without aberrations in endochondral bone formation during embryogenesis or in cartilage development during growth. These findings indicate that Chm-I is critical under conditions of stress such as bone repair through endochondral ossification of a fracture callus. We carried out the present study to examine the expression and role of Chm-I in bone repair using a stabilized tibial fracture model, and compared fracture healing in Chm1 knockout (Chm1−/−) mice with that in wild-type mice. Chm-I mRNA and protein localized in the external cartilaginous callus in the reparative phase of fracture healing. Radiological examination showed a delayed union in Chm1−/− mice although the fracture site was covered with both external and internal calluses. Chm1 null mutation reduced external cartilaginous callus formation as judged by marked decrease of type X collagen alpha 1 (Col10a1) expression and the total amount of cartilage matrix. Interestingly, the majority of chondrocytes in the periosteal callus failed to differentiate into mature chondrocytes in Chm1−/− mice, while the hypertrophic maturation of chondrocytes between the cortices was not affected. These results suggest that Chm-I is involved in hypertrophic maturation of periosteal chondrocytes. Although a direct effect of Chm-I on bones is still unclear, bony callus formation was increased while external cartilaginous callus decreased in Chm1−/− mice. We conclude that in the absence of Chm1, predominant primary bone healing occurs due to an indirect effect induced by reduction of cartilaginous callus rather than to a direct effect on osteogenic function, resulting in a delayed union.
We also recommend Trading Suppliers and Manufacturers of chondromodulin (cas 136362-10-2). Pls Click Website Link as below: cas 136362-10-2 suppliers
Prev:Proteomic analysis of chondromodulin (cas 136362-10-2)-I-induced differentiation of mesenchymal stem cells into chondrocytes
Next:chondromodulin (cas 136362-10-2) I and pleiotrophin gene expression in bovine cartilage and epiphysis) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Generation of multiple transcripts from the chicken chondromodulin (cas 136362-10-2)-I gene and their expression during embryonic development09/10/2019
- Hormones – Cytokines – Signalingchondromodulin (cas 136362-10-2)-I expression in the growth plate of young uremic rats09/09/2019
- Differential expression of Tenomodulin and chondromodulin (cas 136362-10-2)-1 at the insertion site of the tendon reflects a phenotypic transition of the resident cells09/08/2019
- Reviewchondromodulin (cas 136362-10-2)-I and tenomodulin: A new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues09/07/2019
- chondromodulin (cas 136362-10-2) I and pleiotrophin gene expression in bovine cartilage and epiphysis09/06/2019
- Proteomic analysis of chondromodulin (cas 136362-10-2)-I-induced differentiation of mesenchymal stem cells into chondrocytes09/04/2019
- Expression of the chondromodulin (cas 136362-10-2)-I gene in chondrosarcomas09/03/2019
- Cardiovascular diseaseschondromodulin (cas 136362-10-2)-I maintains normal cardiac valves by preventing angiogensis09/02/2019
- chondromodulin (cas 136362-10-2)-1 ameliorates osteoarthritis progression by inhibiting HIF-2α activity09/01/2019


